Patients Coming Off Slimming Jabs Gain Back Weight Far More Rapidly Compared to Those on Conventional Diets

A recent study indicates that patients who come off new GLP-1 drugs like semaglutide or tirzepatide can put back on reduced body mass far faster than those who halt traditional lifestyle programs.

Research printed in a leading medical journal shows that while overweight people often shed a large proportion of their body weight while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month after stopping.

"Users buying these medications must be informed of the danger of fast rebound weight gain when the medication concludes," stated lead investigator Dr. Susan Jebb.

That rate of regain implies a reversion to original weight in about 18 months.

Comparing Therapies

The study, which looked at 37 of trials involving over 9,000 of participants, contrasted the outcomes of the injectable medications with older methods.

Researchers point out that individuals who shed pounds through lifestyle changes alone usually experience a slower weight regain—perhaps 100 grams monthly—after stopping.

Explaining the Fast Regain

Experts believe the mode of action of the injections is key to understanding the amplified rebound.

GLP-1 drugs mimic a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Sustained high doses of the hormone concentrations far above than the body's typical production may cause the body to produce less of its own natural hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this hormone supplement results in appetite is uncontrolled, making excessive eating much more probable."

A Lifelong Condition?

The NHS suggest the jabs for people with obesity-related health risks, accompanied by prescribed lifestyle changes.

Professionals argue that, due to the significant potential of relapse, the treatment might need to be ongoing.

This opinion is echoed by drug manufacturers, who note that the results "underscore the chronic character of excess weight," similar to managing diseases like high blood pressure.

User Testimonies

Users who have come off the medication explain a intense return of hunger.

"It felt as if a trigger activating and you're instantly ravenous," described one woman.

This challenge is exacerbated if individuals have not established permanent dietary or behavioural modifications during treatment.

Widespread Use

Survey data show that millions of people in the UK have used these injections in the last 12 months, with interest remaining high.

• Adoption is higher among females than males.
• The 40s and 50s age group shows the highest level of interest.
• Many access the medications through private prescriptions rather than the NHS.

Finally, experts caution that while GLP-1 drugs are effective agents for shedding pounds, they are not a standalone solution and maintained weight loss likely depends on ongoing lifestyle support.